Endexx Exhibits at 5th Annual SuperZoo Show 2018 in Las Vegas

Company Increases Exposure of its Best Selling CBD Phyto-Bites® Product

CAVE CREEK, AZ, June 26, 2018 (GLOBE NEWSWIRE) -- Endexx Corporation (OTC PINK: EDXC), a provider of innovative phytonutrient-based food and nutritional products, announced today that its best-selling product Phyto-Bites®, will be exhibiting in booth D3076 at the SuperZoo Conference held on June 26-28, 2018 at the Mandalay Bay Convention Center in Las Vegas.

The Company recently launched its new and improved formula for Phyto-Bites®, a CBD-infused soft chew for cats and dogs, which removes all sugar from its ingredients and now include coconut oil and sweet potato for added health benefits. Phyto-Bites ® is formulated to promote quality of health and support the reduction of separation anxiety, pain and inflammation. Controlled dosing and the dual delivery platform drives the success of this highly effective product.

“SuperZoo is one of the most prestigious venues to showcase innovative and exciting products for the pet retail industry,” commented Todd Davis, Chief Executive Officer of Endexx. “Our attendance at last year’s event has created tremendous opportunities for us: we’ve gained a large following and interest for our pet chews, forged strong relationships with industry experts, increased our visibility with the market, expanded our distribution, and secured our partnership with Impulse Health. This year we will continue to educate the nutritional benefits of our CBD product line and demonstrate our market leadership in this space.”

SuperZoo boasts the most buyer participation of any trade show for the pet retail industry in North America, providing pet retail and service professionals with the knowledge and resources they need to be successful. Produced by World Pet Association (WPA) the show attracts around 18,000 retailers, product suppliers and service providers at each annual event.

About Endexx

Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs and cats. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 – the m3hub and the AutoSpense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “end of sale” technology integration. The AutoSpense™ is a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, AutoSpense™ increases productivity and reduces costs for retailers, while enhancing their service quality by reducing transaction time for customers. Websites include , and .

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.